CN101091721A - 阿胶新剂型的制备方法 - Google Patents

阿胶新剂型的制备方法 Download PDF

Info

Publication number
CN101091721A
CN101091721A CNA2006100869879A CN200610086987A CN101091721A CN 101091721 A CN101091721 A CN 101091721A CN A2006100869879 A CNA2006100869879 A CN A2006100869879A CN 200610086987 A CN200610086987 A CN 200610086987A CN 101091721 A CN101091721 A CN 101091721A
Authority
CN
China
Prior art keywords
component
radix
preparation
corii asini
colla corii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CNA2006100869879A
Other languages
English (en)
Inventor
孙明
陈倩洁
陈旭群
张玫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2006100869879A priority Critical patent/CN101091721A/zh
Publication of CN101091721A publication Critical patent/CN101091721A/zh
Withdrawn legal-status Critical Current

Links

Abstract

本发明是一种阿胶新剂型的制备方法,其为由E组分和F组分按任意比例混合制成的胶囊或者滴丸剂或者丸剂或者片剂,其中,E组分为阿胶粉,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七、桂圆、枸杞、当归、何首乌的提取物、细粉或超微粉碎细粉中的任意一种,或者一种以上按任意比例混合在一起。该方法不仅基本解决了阿胶难去腥味的老问题,而且拓展了阿胶的剂型,将阿胶作为食品、保健食品或者保健品的用法进一步丰富。所制阿胶粉及其制品具有便于携带、利于吸收、口感好的特点。

Description

阿胶新剂型的制备方法
技术领域  本发明涉及一种阿胶粉的制备方法,并涉及利用所制阿胶粉制备的阿胶制品新剂型。
背景技术  众所周知,作为食品、保健食品或者保健品的阿胶,具有非常高的营养价值。目前,阿胶的剂型主要有口服液和胶剂两种。其中,口服液的主要优点是胶质溶解分散较好,利于人体吸收,但它存在携带不便和易于渗漏的问题。胶剂的主要缺点是服用不够方便,因为它需要事先进行烊化后方能服用。
口服液和胶剂还存在一个共同缺点,就是带有一种来自动物皮的腥味,口感不够好。
发明内容  本发明的目的是通过提供一种阿胶新剂型的制备方法,解决以下技术问题:第一、将阿胶制备成为阿胶纳米粉并基本去处其腥味;第二、利用所制纳米阿胶粉与其它中药或者食品成份配制成各种剂型阿胶制品。
为了解决这些技术问题,本发明采用了以下技术方案。
一种纳米阿胶粉的制备方法,其特征是:其经由以下步骤,
第一步:将聚乙二醇、聚乙二醇重量0--30%的蜂胶助溶剂混合,加入聚乙二醇和蜂胶助溶剂总量1-10倍的纯化水,在容器中60-80℃水浴加热至聚乙二醇融化,制成A组分;
第二步:将碎块状阿胶按阿胶∶A组分=1∶5-10的比例加入到A组分中,60-80℃水浴保持10-30分钟,制成B组分;
第三步将卵磷脂按卵磷脂∶B组分=0.1-10∶100的比例加入到B组分中,连续搅拌至基本均匀后,经超声振动5-60分钟,在-30℃下冷冻1-3小时,然后冷冻干燥,制成C组分;
第四步:将C组分溶于10-60倍的纯化水中,然后用0.2μm微孔滤膜过滤,所得纳米滤液为D组分;
第五部:将D组分依次喷雾干燥、冷冻干燥、真空旋转干燥,制成阿胶粉,称为E组分。
利用所述的纳米阿胶粉制备的阿胶制品,其特征是:其为由E组分和F组分按任意比例混合制成的胶囊或者滴丸剂或者丸剂或者片剂,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七、桂圆、枸杞、当归、何首乌的提取物、细粉或超微粉碎细粉中的任意一种,或者一种以上按任意比例混合在一起。
本发明具有以下积极效果:(1)、首次提出阿胶纳米粉的制备方法,该方法不仅基本解决了阿胶难去腥味的老问题,而且拓展了阿胶的剂型,将阿胶作为食品、保健食品或者保健品的用法进一步丰富。(2)、所制阿胶粉及其制品具有便于携带、利于吸收、口感好的特点。
具体实施方式  下面结合若干实施例,对本发明作进一步阐述。
纳米阿胶粉制备例
第一步:将聚乙二醇和等量的纯化水在容器中60-80℃水浴加热至聚乙二醇融化,制成A组分;
第二步:将碎块状阿胶按阿胶∶A组分=1∶7的比例加入到A组分中,60-80℃水浴保持10-30分钟,制成B组分;
第三步将卵磷脂按卵磷脂∶B组分=0.1∶100的比例加入到B组分中,连续搅拌至基本均匀后,经超声振动5分钟,在-30℃下冷冻1小时,然后冷冻干燥,制成C组分;
第四步:将C组分溶于10倍的纯化水中,然后用0.2μm微孔滤膜过滤,所得纳米滤液为D组分;
第五部:将D组分依次喷雾干燥、冷冻干燥、真空旋转干燥,制成纳米阿胶粉。
纳米阿胶胶囊制备例
将制成的阿胶粉简称为E组分,E组分和F组分按100∶30比例混合,按胶囊常规工艺制成胶囊,
其中,F组分为蜂花粉的超微粉碎细粉。
纳米阿胶胶囊制备例二
将制成的阿胶粉简称为E组分,E组分和F组分按100∶80比例混合,按胶囊常规工艺制成胶囊,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七的提取物按1∶1∶1∶1∶1∶1∶1∶1比例复配。
纳米阿胶胶囊制备例三
将制成的阿胶粉简称为E组分,E组分和F组分按100∶120比例混合,按胶囊常规工艺制成胶囊,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七、桂圆、枸杞、当归、何首乌的细粉按1∶1.2∶0.1∶2∶3∶0.5∶1.5∶1∶0.8∶1.8∶3∶2比例复配。、
纳米阿胶片剂制备例
将制成的阿胶粉简称为E组分,E组分和F组分按100∶120比例混合,按片剂常规工艺制成片剂,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七、桂圆、枸杞、当归、何首乌的细粉按1∶1.2∶0.1∶2∶3∶0.5∶1.5∶1∶0.8∶1.8∶3∶2比例复配。
纳米阿胶丸剂制备例一
将制成的阿胶粉简称为E组分,E组分和F组分按100∶80比例混合,按丸剂常规工艺制成丸剂,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七的提取物按1∶1∶1∶1∶1∶1∶1∶1比例复配。
纳米阿胶滴丸剂制备例一
将制成的阿胶粉简称为E组分,E组分和F组分按100∶30比例混合,按滴丸剂常规工艺制成滴丸剂,
其中,F组分为西洋参的超微粉碎细粉。

Claims (2)

1、一种纳米阿胶粉的制备方法,其特征是:其经由以下步骤,
第一步:将聚乙二醇、聚乙二醇重量0--30%的蜂胶助溶剂混合,加入聚乙二醇和蜂胶助溶剂总量1-10倍的纯化水,在容器中60-80℃水浴加热至聚乙二醇融化,制成A组分;
第二步:将碎块状阿胶按阿胶∶A组分=1∶5-10的比例加入到A组分中,60-80℃水浴保持10-30分钟,制成B组分;
第三步将卵磷脂按卵磷脂∶B组分=0.1-10∶100的比例加入到B组分中,连续搅拌至基本均匀后,经超声振动5-60分钟,在-30℃下冷冻1-3小时,然后冷冻干燥,制成C组分;
第四步:将C组分溶于10-60倍的纯化水中,然后用0.2μm微孔滤膜过滤,所得纳米滤液为D组分;
第五部:将D组分依次喷雾干燥、冷冻干燥、真空旋转干燥,制成阿胶粉,称为E组分。
2、利用权利要求1所述的纳米阿胶粉制备的阿胶制品,其特征是:其为由E组分和F组分按任意比例混合制成的胶囊或者滴丸剂或者丸剂或者片剂,
其中,F组分为蜂花粉、西洋参、人参、熟地黄、山楂、党参、山药、三七、桂圆、枸杞、当归、何首乌的提取物、细粉或超微粉碎细粉中的任意一种,或者一种以上按任意比例混合在一起。
CNA2006100869879A 2006-06-22 2006-06-22 阿胶新剂型的制备方法 Withdrawn CN101091721A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006100869879A CN101091721A (zh) 2006-06-22 2006-06-22 阿胶新剂型的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2006100869879A CN101091721A (zh) 2006-06-22 2006-06-22 阿胶新剂型的制备方法

Publications (1)

Publication Number Publication Date
CN101091721A true CN101091721A (zh) 2007-12-26

Family

ID=38990279

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100869879A Withdrawn CN101091721A (zh) 2006-06-22 2006-06-22 阿胶新剂型的制备方法

Country Status (1)

Country Link
CN (1) CN101091721A (zh)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110082214A1 (en) * 2008-05-09 2011-04-07 Gruenthal Gmbh Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
CN101692908B (zh) * 2009-10-19 2013-06-26 浙江省医学科学院 一种具有补血、养颜、美容功能的双胶花粉食品及其制备方法
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US9655853B2 (en) 2012-02-28 2017-05-23 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US9675610B2 (en) 2002-06-17 2017-06-13 Grünenthal GmbH Abuse-proofed dosage form
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US9855263B2 (en) 2015-04-24 2018-01-02 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9925146B2 (en) 2009-07-22 2018-03-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US10335373B2 (en) 2012-04-18 2019-07-02 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10449547B2 (en) 2013-11-26 2019-10-22 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
US10695297B2 (en) 2011-07-29 2020-06-30 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US10729658B2 (en) 2005-02-04 2020-08-04 Grünenthal GmbH Process for the production of an abuse-proofed dosage form
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US11224576B2 (en) 2003-12-24 2022-01-18 Grünenthal GmbH Process for the production of an abuse-proofed dosage form
US11844865B2 (en) 2004-07-01 2023-12-19 Grünenthal GmbH Abuse-proofed oral dosage form

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9675610B2 (en) 2002-06-17 2017-06-13 Grünenthal GmbH Abuse-proofed dosage form
US10369109B2 (en) 2002-06-17 2019-08-06 Grünenthal GmbH Abuse-proofed dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
US11224576B2 (en) 2003-12-24 2022-01-18 Grünenthal GmbH Process for the production of an abuse-proofed dosage form
US11844865B2 (en) 2004-07-01 2023-12-19 Grünenthal GmbH Abuse-proofed oral dosage form
US10729658B2 (en) 2005-02-04 2020-08-04 Grünenthal GmbH Process for the production of an abuse-proofed dosage form
US10675278B2 (en) 2005-02-04 2020-06-09 Grünenthal GmbH Crush resistant delayed-release dosage forms
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US9161917B2 (en) * 2008-05-09 2015-10-20 Grünenthal GmbH Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US20110082214A1 (en) * 2008-05-09 2011-04-07 Gruenthal Gmbh Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US10493033B2 (en) 2009-07-22 2019-12-03 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US9925146B2 (en) 2009-07-22 2018-03-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
CN101692908B (zh) * 2009-10-19 2013-06-26 浙江省医学科学院 一种具有补血、养颜、美容功能的双胶花粉食品及其制备方法
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US10864164B2 (en) 2011-07-29 2020-12-15 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US10695297B2 (en) 2011-07-29 2020-06-30 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US9655853B2 (en) 2012-02-28 2017-05-23 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US10335373B2 (en) 2012-04-18 2019-07-02 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
US10449547B2 (en) 2013-11-26 2019-10-22 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9913814B2 (en) 2014-05-12 2018-03-13 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
US9855263B2 (en) 2015-04-24 2018-01-02 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Similar Documents

Publication Publication Date Title
CN101091721A (zh) 阿胶新剂型的制备方法
CN100427102C (zh) 一种纳米阿胶粉的制备方法及其阿胶制品
CN109939075A (zh) 一种中药泡腾片及其制备方法
CN104524424A (zh) 一种美容排毒祛斑口服液及其制备方法
CN101780115A (zh) 中兽药微囊制剂及其制备方法
CN105943566A (zh) 水溶性硅与中药材或食材提取物之复方制剂的制备方法
CN101317890A (zh) 一种适用于泌尿系结石胶囊的制作方法
CN103285137A (zh) 一种含阿胶的速溶颗粒及其制备方法
CN101632691A (zh) 紫地榆泡腾剂
CN103655908A (zh) 新型复方阿胶浆及其制备工艺
CN103655898B (zh) 可治疗痛经的复方阿胶浆
CN1634213A (zh) 参芪胶生血中药制剂
CN106668363A (zh) 一种妇产科用消炎止血的中药及其制备方法
CN105709151A (zh) 一种调五脏、补命门、通心脑、滋阴强肾的天然中药制剂及其制备方法
CN1491584A (zh) 鹿茸咀嚼片
CN101623364A (zh) 一种用于治疗便秘的药茶及其制法
CN103989983A (zh) 一种黑芝麻苦参泡腾片及其制备方法
CN104509847A (zh) 一种治疗口臭的蜜丸
CN101632693A (zh) 紫地榆膜剂
CN103690669A (zh) 可健脾胃的复方阿胶浆及其制备工艺
CN1053588C (zh) 生发乌发丸的制作方法
CN103550369A (zh) 一种具有改善睡眠功效的保健品
CN102552623A (zh) 一种滋阴补肾、生精填髓的中药及其制备方法
CN102727652A (zh) 一种用于增强记忆力的中药组合物及其制备方法和应用
CN106491944A (zh) 天王补心丸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication